Antiplatelet agents aspirin oral. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Blood Platelets Melena

Diseases36

Thrombosis Hemorrhage Acute Coronary Syndrome Stroke Thromboembolism Coronary Thrombosis Postoperative Hemorrhage Myocardial Infarction Recurrence Cerebrovascular Disorders Ischemic Attack, Transient Intracranial Hemorrhages Cerebral Hemorrhage Coronary Artery Disease Brain Ischemia Cardiovascular Diseases Peripheral Vascular Diseases Atrial Fibrillation Coronary Disease Myocardial Ischemia Postoperative Complications Gastrointestinal Hemorrhage Thrombocytopenia Purpura, Thrombocytopenic Graft Occlusion, Vascular Embolism Intracranial Thrombosis Asthma, Aspirin-Induced Carotid Artery Thrombosis Hematoma Embolism, Cholesterol Angina, Unstable Melena Blood Loss, Surgical Coronary Restenosis Purpura, Thrombocytopenic, Idiopathic

Chemicals and Drugs58

Aspirin Platelet Aggregation Inhibitors Ticlopidine Thienopyridines Anticoagulants Dipyridamole Purinergic P2Y Receptor Antagonists Thiophenes Receptors, Purinergic P2Y12 Fibrinolytic Agents Platelet Glycoprotein GPIIb-IIIa Complex Warfarin Dilazep Phosphodiesterase 3 Inhibitors Purinergic P2 Receptor Antagonists Tetrazoles Anti-Inflammatory Agents, Non-Steroidal Piperazines Cardiovascular Agents Immunoglobulin Fab Fragments Adenosine Diphosphate Thromboxane B2 Vitamin K Heparin Phenprocoumon Adenosine Pyridines Receptor, PAR-1 Cyclooxygenase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Angiotensin-Converting Enzyme Inhibitors Thrombin Salicylates Adrenergic beta-Antagonists Collagen Sulfinpyrazone Thromboxanes Tablets, Enteric-Coated Thromboxane A2 Cyclooxygenase 1 Antibodies, Monoclonal Sodium Salicylate Prostaglandin-Endoperoxide Synthases Epoprostenol Cyclooxygenase 2 Inhibitors P-Selectin Platelet Membrane Glycoproteins Phenazopyridine Thromboxane-A Synthase Proton Pump Inhibitors Acenocoumarol Heparin, Low-Molecular-Weight Antithrombins Aryl Hydrocarbon Hydroxylases Drug Combinations 6-Ketoprostaglandin F1 alpha Ibuprofen Arachidonic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment27

Platelet Function Tests Bleeding Time Drug Therapy, Combination Treatment Outcome Risk Factors Stents Angioplasty, Balloon, Coronary Perioperative Care Administration, Oral Prospective Studies Risk Assessment Follow-Up Studies Randomized Controlled Trials as Topic Double-Blind Method Thrombolytic Therapy Retrospective Studies Clinical Trials as Topic Incidence Registries Drug-Eluting Stents Platelet Count Thrombelastography Drug Administration Schedule Percutaneous Coronary Intervention International Normalized Ratio Coronary Angiography Premedication

Phenomena and Processes10

Platelet Aggregation Bleeding Time Platelet Activation Platelet Adhesiveness Time Factors Drug Resistance Dose-Response Relationship, Drug Platelet Count Drug Interactions Blood Coagulation

Information Science2

Incidence Registries

Health Care15

Treatment Outcome Secondary Prevention Risk Factors Perioperative Care Prospective Studies Risk Assessment Follow-Up Studies Randomized Controlled Trials as Topic Double-Blind Method Retrospective Studies Clinical Trials as Topic Incidence Practice Guidelines as Topic Registries Primary Prevention

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Aspirin Platelet Aggregation Inhibitors Ticlopidine Platelet Aggregation Thrombosis Platelet Function Tests Thienopyridines Hemorrhage Anticoagulants Dipyridamole Bleeding Time Purinergic P2Y Receptor Antagonists Blood Platelets Thiophenes Drug Therapy, Combination Receptors, Purinergic P2Y12 Fibrinolytic Agents Platelet Activation Platelet Glycoprotein GPIIb-IIIa Complex Acute Coronary Syndrome Warfarin Stroke Dilazep Treatment Outcome Thromboembolism Coronary Thrombosis Secondary Prevention Phosphodiesterase 3 Inhibitors Risk Factors Postoperative Hemorrhage Purinergic P2 Receptor Antagonists Stents Tetrazoles Angioplasty, Balloon, Coronary Anti-Inflammatory Agents, Non-Steroidal Myocardial Infarction Piperazines Perioperative Care Cardiovascular Agents Immunoglobulin Fab Fragments Adenosine Diphosphate Recurrence Cerebrovascular Disorders Thromboxane B2 Ischemic Attack, Transient Administration, Oral Intracranial Hemorrhages Platelet Adhesiveness Prospective Studies Time Factors Drug Resistance Risk Assessment Follow-Up Studies Vitamin K Heparin Cerebral Hemorrhage Coronary Artery Disease Brain Ischemia Cardiovascular Diseases Randomized Controlled Trials as Topic Dose-Response Relationship, Drug Peripheral Vascular Diseases Phenprocoumon Double-Blind Method Thrombolytic Therapy Retrospective Studies Adenosine Pyridines Atrial Fibrillation Receptor, PAR-1 Clinical Trials as Topic Cyclooxygenase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Coronary Disease Incidence Practice Guidelines as Topic Angiotensin-Converting Enzyme Inhibitors Thrombin Salicylates Registries Adrenergic beta-Antagonists Collagen Drug-Eluting Stents Myocardial Ischemia Sulfinpyrazone Thromboxanes Platelet Count Postoperative Complications Tablets, Enteric-Coated Thromboxane A2 Gastrointestinal Hemorrhage Cyclooxygenase 1 Antibodies, Monoclonal Drug Interactions Thrombocytopenia Thrombelastography Drug Administration Schedule Purpura, Thrombocytopenic Sodium Salicylate Graft Occlusion, Vascular

No FAQ available that match "antiplatelet agents aspirin oral"